search
Back to results

Inhibitory Control of the Mind : Neural Bases and Impact for Obsessive-compulsive Disorders (SUPTOC)

Primary Purpose

Obsessive Compulsive Disorder, Healthy

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Functional magnetic resonance imaging
behavioral measures
physiological measurements
Sponsored by
University Hospital, Caen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Obsessive Compulsive Disorder focused on measuring suppression mnemonic, emotional response, inhibitory control of failures, neurological alterations

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria :

  • All the participants :

    • Participants between 18 and 55 years old
    • Affiliated to the French national health care system
    • French native speaker
    • Right-handed
    • At least education after graduating with french GSCE "brevet des collèges"
    • Body mass < 35kg/m2
  • Healthy subjects :

    • Signed written consent form
  • Patients :

    • Patients with OCD according to DSM V diagnostic criteria at the time of the study
    • Stabilized (no change of psychotropic drugs during the last 3 months)
    • Signed written consent form associated with the agreement of the tutor and / or curator for protected adults

Exclusion Criteria:

  • All the participants :

    • Pregnancy or intent to get pregnant
    • Person deprived of their liberty
    • Person admitted to a health or social institution for purposes other than research
    • Minor
    • Protected adults or people unable to give informed consent
    • Person subjected to an exclusion period related to another protocol
    • History of cancer with the last 5 years, excluding squamous cell carcinomas
    • Alcoholism, antecedents of chronic alcoholism or drugs abuse
    • Use of medication that may interfere with cognitive or cerebral functioning
    • Presence of visual or hearing troubles that may compromise participant's ability to participate in the study
    • MRI Contraindications
  • Healthy subjects :

    • History of neurological or psychiatric disorders or existence of traumatic brain injury with loss of consciousness for more than one hour
    • Severe psychiatric disorders (according to DSM V diagnostic criteria) or psychological troubles which could affect participant's judgment
  • Patients :

    • Presence of neurological history, history of head trauma with loss of consciousness for more than an hour, severe depression, manic symptoms, post-traumatic stress, borderline personality disorder, antisocial, paranoid or schizoid.

Sites / Locations

  • GIP Cyceron

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

patients with obsessive compulsive disorder

healthy participants

Arm Description

Functional magnetic resonance imaging behavioral measures physiological measurements

Functional magnetic resonance imaging behavioral measures physiological measurements

Outcomes

Primary Outcome Measures

Blood Oxigen Level Dependent (BOLD) response as measured with fMRI

Secondary Outcome Measures

Full Information

First Posted
May 27, 2016
Last Updated
July 27, 2016
Sponsor
University Hospital, Caen
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Centre National de la Recherche Scientifique, France, Université de Caen Normandie
search

1. Study Identification

Unique Protocol Identification Number
NCT02850393
Brief Title
Inhibitory Control of the Mind : Neural Bases and Impact for Obsessive-compulsive Disorders
Acronym
SUPTOC
Official Title
Etude en Imagerie Par résonance magnétique Fonctionnelle et Structurelle Des mécanismes de Suppression mnésique Dans Les Troubles Obsessionnels Compulsifs
Study Type
Interventional

2. Study Status

Record Verification Date
July 2016
Overall Recruitment Status
Unknown status
Study Start Date
July 2016 (undefined)
Primary Completion Date
March 2019 (Anticipated)
Study Completion Date
December 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Caen
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Centre National de la Recherche Scientifique, France, Université de Caen Normandie

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Mental-health conditions affect million people worldwide. The economic burden of mental illness is enormous and the economic health of both developing and developed nations will depend on controlling the staggering growth in costs from mental disorders. Obsessive-compulsive disorder (OCD) is a relatively common and frequent form of anxiety that affects approximately 2-3% of the population. OCD is characterized by anxiety, obsessions (persistent intrusive thoughts and images with highly distressing contents) and compulsions (repetitive activity), and severely impairs the lives of those affected. Despite their interest as effective and affordable care and rehabilitation, cognitive therapeutic profits too little from the increasing accumulation of knowledge in neuroscience, and neuroscientists pay too little attention to the challenges faced by clinical psychologists and psychiatrists. To reduce this cultural gap, two teams specialized in the study and multimodal imaging of healthy participants and clinical patients with mental health disorders, the UMR-S INSERM-EPHE-UNICAEN U1077 unit led by Francis Eustache, and ISTS team (UMR-S 6301 CNRS-CEA-UCBN) led by Sonia Dollfus, will joint their efforts to develop an integrated approach of the neural mechanisms at stake from basic neuroscience using state-of-art neuroimaging techniques, to novel and ground breaking psychological intervention. Both teams evolve at the brain imaging Cyceron center in Caen in connection with the Mental Health and Addictology Center, offering unique opportunities for such translational research. This project will capitalize on recent evidence showing that healthy participants can prevent unwanted images from entering consciousness using inhibitory control and memory suppression techniques, disrupting traces of the memories in sensory areas of the brain, and weakening their vividness and later reentrance. OCD is characterized by aberrant and excessive visual intrusions, usually extremely vivid, detailed, and unpleasant. These distressing images are particularly uncontrollable and may frequently initiate compulsive rituals. In a first phase of this proposal will use functional magnetic resonance imaging (fMRI) to develop a neurobiological model of the cognitive computations achieved by inhibition network to suppress memory. To achieve this goal we will develop an attentional model of healthy memory inhibition functioning, simulating the deployment of attentional resources and the different mental processes at stake during suppression. Using sophisticated analyzing tools of fMRI data, we will use this model to decode and infer the representational content of the brain inhibition network, and further refine the connectivity pathways which underlie such control. The lack of a strong neurobiological model prevents the development of therapies which would increase functionality of this network and optimize intervention aiming to disrupt mental intrusions and obsessions. In a second phase, we will assess whether memory suppression may be transferred and trained in OCD patients using images depicting their own obsessions, as a promising avenue to reduce their symptoms on the long run. In addition, fMRI and other brain structural acquisitions will be collected before and after cognitive training to memory suppression, offering a unique opportunity to observe the online dysfunction of intrusion control in OCD patients and to identify neurobiological markers predictive of training outcome and network reconfiguration with training. A fundamental goal of motivated forgetting involves not only to exclude unwelcome content from consciousness but also to reduce their later emotional impact by doing so. In parallel of these two main phases, we will thus also measure physiological markers of autonomic nervous system activity changes in response to suppressed images to better identify the consequences of memory suppression on emotional states, anxiety, and mental health in general.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obsessive Compulsive Disorder, Healthy
Keywords
suppression mnemonic, emotional response, inhibitory control of failures, neurological alterations

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
patients with obsessive compulsive disorder
Arm Type
Experimental
Arm Description
Functional magnetic resonance imaging behavioral measures physiological measurements
Arm Title
healthy participants
Arm Type
Experimental
Arm Description
Functional magnetic resonance imaging behavioral measures physiological measurements
Intervention Type
Other
Intervention Name(s)
Functional magnetic resonance imaging
Intervention Type
Behavioral
Intervention Name(s)
behavioral measures
Intervention Type
Other
Intervention Name(s)
physiological measurements
Primary Outcome Measure Information:
Title
Blood Oxigen Level Dependent (BOLD) response as measured with fMRI
Time Frame
1 hour

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria : All the participants : Participants between 18 and 55 years old Affiliated to the French national health care system French native speaker Right-handed At least education after graduating with french GSCE "brevet des collèges" Body mass < 35kg/m2 Healthy subjects : Signed written consent form Patients : Patients with OCD according to DSM V diagnostic criteria at the time of the study Stabilized (no change of psychotropic drugs during the last 3 months) Signed written consent form associated with the agreement of the tutor and / or curator for protected adults Exclusion Criteria: All the participants : Pregnancy or intent to get pregnant Person deprived of their liberty Person admitted to a health or social institution for purposes other than research Minor Protected adults or people unable to give informed consent Person subjected to an exclusion period related to another protocol History of cancer with the last 5 years, excluding squamous cell carcinomas Alcoholism, antecedents of chronic alcoholism or drugs abuse Use of medication that may interfere with cognitive or cerebral functioning Presence of visual or hearing troubles that may compromise participant's ability to participate in the study MRI Contraindications Healthy subjects : History of neurological or psychiatric disorders or existence of traumatic brain injury with loss of consciousness for more than one hour Severe psychiatric disorders (according to DSM V diagnostic criteria) or psychological troubles which could affect participant's judgment Patients : Presence of neurological history, history of head trauma with loss of consciousness for more than an hour, severe depression, manic symptoms, post-traumatic stress, borderline personality disorder, antisocial, paranoid or schizoid.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anaïs Vandevelde, MD
Organizational Affiliation
University Hospital, Caen
Official's Role
Principal Investigator
Facility Information:
Facility Name
GIP Cyceron
City
Caen
State/Province
Calvados
ZIP/Postal Code
14000
Country
France

12. IPD Sharing Statement

Learn more about this trial

Inhibitory Control of the Mind : Neural Bases and Impact for Obsessive-compulsive Disorders

We'll reach out to this number within 24 hrs